Literature DB >> 19371222

Cytogenetic activity of diazepam in normal human lymphocyte cultures.

Kyriaki Akritopoulou1, Zafiroula Iakovidou-Kritsi, Eleutheria Mioglou-Kalouptsi, Maria T Ekonomopoulou, Dionysios Mourelatos.   

Abstract

INTRODUCTION: Diazepam (DZ) belongs to benzodiazepines, a group of drugs used for sedation, for the relief of anxiety, and in the treatment of epilepsy. It has been found that DZ influences cytotoxic activity and diminishes antiviral and antitumor reactions in human natural killer cells in vitro. It has also been demonstrated that DZ causes a significant increase in the frequency of chromosomal aberrations in human lymphocytes in vitro.
MATERIALS AND METHODS: In the present research the cytogenetic effects of DZ have been studied in normal human lymphocyte cultures of peripheral blood at 17.6-211.2 microM (final concentrations). Sister chromatid exchanges (SCEs), one of the most sensitive methods reflecting instability in DNA or a deficiency in DNA repair mechanisms, and proliferation rate index (PRI), a valuable indicator for cytostatic activity, have been evaluated.
RESULTS: After 72-h incubation, DZ was found to cause a dose-dependent, statistically significant increase of SCE frequency (p < 0.001), followed by an equally significant decrease of PRI (p < 0.001).
CONCLUSION: Our results suggest that DZ's administration presents cytogenetic effects in normal human lymphocyte cultures.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19371222     DOI: 10.1089/gtmb.2008.0116

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  2 in total

1.  Benzodiazepines and risk of pneumonia in schizophrenia: a nationwide case-control study.

Authors:  Sheng-Yun Cheng; Wen-Yin Chen; Hsing-Cheng Liu; Tien-Wei Yang; Chun-Hung Pan; Shu-Yu Yang; Chian-Jue Kuo
Journal:  Psychopharmacology (Berl)       Date:  2018-09-19       Impact factor: 4.530

Review 2.  Immunosuppressive aspects of analgesics and sedatives used in mechanically ventilated patients: an underappreciated risk factor for the development of ventilator-associated pneumonia in critically ill patients.

Authors:  Michael A Smith; Maho Hibino; Bonnie A Falcione; Katherine M Eichinger; Ravi Patel; Kerry M Empey
Journal:  Ann Pharmacother       Date:  2013-11-04       Impact factor: 3.154

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.